Should I buy Home BancShares (HOMB) stock or is it too late?
⭐ The most reliable of them, either direction: Piper Sandler — 73% of its targets hit on this sector (235 calls tested). It aims for $36 (+21 %), call made on July 18, 2026, maturing on July 18, 2027 (41 d ago).
Firm-by-firm track record on Home BancShares
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| Raymond James | 71 % | +27.8 % | 7 | $30 +1% |
| Stephens & Co. | 77 % | +15.6 % | 13 | $35 +18% |
| Keefe, Bruyette & Woods | 80 % | +13.0 % | 5 | $32 +8% |
| Piper Sandler | 73 % | +11.0 % | 11 | $36 +21% |
| Wunderlich Securities | 88 % | +51.9 % | 8 | — |
✅ Reasons to believe
- Median price target $32, i.e. +8% from the current price ($30).
- The most reliable firm on HOMB, Keefe, Bruyette & Woods (80% hit rate, 5 scored calls), targets $32 (call made on July 17, 2026, maturing on July 17, 2027) (+8%) in its most recent call, and $30 (call made on April 20, 2026, maturing on April 20, 2027) (+1%) in the one coming due soonest.
- Pays a dividend (2.9% yield), raised for 15 years — regular income on top of potential upside.
⚠️ Reasons to hesitate
- The consensus is not unanimous: of 6 ratings, 4 are neutral.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
The analyst consensus on HOMB
Median target $32 (+8%) · 6 ratings · Hold consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in Home BancShares now?
We won't decide for you. The facts: 33% of analysts rate it a buy, median target $32 (+8%), and Keefe, Bruyette & Woods (most reliable on HOMB, 80%) targets $32. Weigh that against valuation. This is not personalized advice.
Is it too late to invest in Home BancShares?
Not according to analysts: the median target ($32) is still +8% above the current price ($30) (most reliable on HOMB: Keefe, Bruyette & Woods, 80%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is Home BancShares still worth investing in?
It depends on the gap between the price ($30) and its estimated value: analysts target $32 on median (+8%), with 33% buys (most reliable on HOMB: Keefe, Bruyette & Woods, 80%). Cross-check with their real reliability on HOMB and the cautions above. Information, not advice.
What's the main risk in buying HOMB?
The consensus is not unanimous: of 6 ratings, 4 are neutral.
→ Go deeper: the full Home BancShares profile (consensus, analyst reliability, price target, performance).